HOME >> BIOLOGY >> NEWS
Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease

Blacksburg, Va., June 10, 2004 Virginia Bioinformatics Researcher Brett Tyler and his colleagues are one step closer to finding a cure for a disease affecting California oak trees that is now showing up in nurseries in a dozen states, including Virginia, and threatening woody ornamentals and East Coast forests.

Tyler and his colleagues have successfully mapped the genome of the devastating pathogens Phytophtora sojae and Phytophtora ramorum. P. ramorum, also known as sudden oak death, is a serious fungal pathogen that has attacked and killed tens of thousands of California and Oregon oak trees. P. sojae, the sister pathogen to P. ramorum, causes serious damage to soybean crops and cost growers $1 billion worldwide last year.

The sequences of P. sojae will act as a "Rosetta Stone" to help researchers better understand P. ramorum's genome makeup and uncover valuable information to help cure and prevent sudden oak death disease. In addition, the sequencing of the P. ramorum genome represents the fastest tracking time between the identification of a complex pathogen (in 2000) and the completion of its genome (in 2004).

Tyler, along with representatives from the Department of Energy Joint Genome Institute (JGI at www.jgi.doe.gov), United States Department of Agriculture (USDA), USDA Forest Service, the National Science Foundation (NSF) and others will present the scientific findings to the media on June 10, 2004 at the Joint Genome Institute in Walnut Creek, California.

Sudden oak death disease has the potential to affect forests in the Appalachian highlands in Virginia and other areas on the East Coast. The disease kills the oak tree, but usually the carrier shrubs survive. Sudden oak death has affected California redwood seedlings and sprouts, but not the trunks. However, it poses a large threat to Virginia oak trees and other Eastern Seaboard plant species that have proven highly susceptible to the pathogen in greenhouse tests. Tyler i
'"/>

Contact: Blanche O'Neill
oneill@vbi.vt.edu
540-231-1976
Virginia Tech
10-Jun-2004


Page: 1 2

Related biology news :

1. Two Virginia Tech energy-related inventions win R&D 100 awards
2. Virginia Tech researchers to release findings on Smith River Project
3. Virginia Tech professor honored with DeLaval Award
4. Virginia Techs smelly corpse plant due to bloom Aug. 4
5. Virginia Center for Coal and Energy Research helps implement global climate change initiative
6. Cell cycle research earns biologist Virginias top scientist award
7. Virginia Tech-led group receives third five-year international biodiversity grant
8. Virginia Tech researcher receives $1.8 million to study Arabidopsis genome
9. Virginia Tech and North Carolina State University to run Forest Nutrition Research Cooperative
10. Virginia Bioinformatics Institute central to Regional Center of Excellence
11. NIH awards $1 million to Virginia Bioinformatics Institute to study biochemical network modeling

Post Your Comments:
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
(Date:10/15/2014)... Alt will be awarded the 44th Rosenstiel Award for ... his pioneering research exploring the mechanisms of genomic instability ... cells. Alt is the second alumnus to win the ... Prize in 2003. , Alt is the Charles A. ... Harvard Medical School and an investigator at the Howard ...
(Date:10/14/2014)... N.Y. – Scientists have sequenced the house fly genome ... one might expect from an insect that thrives in ... published Oct. 14 in the journal Genome Biology ... biology and of how flies quickly adapt to resist ... Adult house flies (Musca domestica) carry and transmit more ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech ... company tackling big healthcare problems, announced today the ... round, with participation from Invesco Perpetual, a $120 ... used to drive PureTech,s existing pipeline forward and ... "PureTech has the scientific creativity to really go ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: